California-based medical technologies developer Cytori Therapeutics has obtained U.S. Patent No. 7,501,115, which covers methods of cooling and cryopreserving stem and regenerative cells processed by the Celution System.

This patent provides additional protection for the company’s cell banking platform, the StemSource Cell Bank, which Cytori is currently commercializing in both Europe and Asia.

The U.S. Patent No. 7,501,115 (115 Patent) protects another specific commercial application of the core Celution System technology, which is covered under U.S. Patent No. 7,390,484 (484 patent), issued in July 2008. In addition to the 484 patent, the company now has three patents covering various formulations and applications of the Celution System output.